Sorako Wakugawa
Okinawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CHANGES IN WIDEFIELD CHOROIDAL THICKNESS AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Journal: Retina (Philadelphia, Pa.)
Published: September 02, 2025
One-year choroidal thickness changes after photodynamic therapy for central serous chorioretinopathy evaluated by widefield optical coherence tomography.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: April 10, 2024
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan.
Journal: Scientific reports
Published: January 25, 2024
Scleral Thickness in Simple Versus Complex Central Serous Chorioretinopathy.
Journal: American journal of ophthalmology
Published: September 17, 2023
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: June 02, 2023
SCLERAL THICKNESS IN THE FELLOW EYES OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: June 01, 2023
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Journal: Scientific reports
Published: January 08, 2023
Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.
Journal: Japanese journal of ophthalmology
Published: December 21, 2021
CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: December 15, 2021
Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.
Journal: Ophthalmology science
Published: August 08, 2021
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: June 29, 2021
Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy.
Journal: Ophthalmology science
Published: May 26, 2021
Last Updated: 09/26/2026